Eurogentec enters in the Therapeutic Oligonucleotides Manufacturing Field

Products & Services

Combining over 30 years of expertise in oligonucleotide synthesis to 20 years of biopharmaceutical GMP manufacturing, we now offer GMP therapeutic oligonucleotides manufacturing for early clinical phases.

GMP certification by the Belgium Authorities for the manufacturing and quality control of therapeutic oligonucleotides according to ICH Q7 is planned for Q1 2019.

 

 

Attached Files

Trending Now

COVID-19: Build your tactics to fight de pandemic

Next post

Recommended for you

Eurogentec joins MabDesign

Company

Eurogentec is pleased to announce its membership in MabDesign, a leading European network dedicated to...
Continue Reading
4-6 November 2026

EMMD

Noordwijk, NL

Join us at "EMMD"

@ Noordwijk, NL
📅November 4-6, 2026
📍Noordwijk (NL) - Booth #14...
Continue Reading
16-19 November 2026

MEDICA

Düsseldorf, DE

Meet our team at "MEDICA"

@ Düsseldorf, DE
📅 November 16-19, 2026
📍Dusseldorf (DE) - AWEX Belgian Pavilion - Hall 01 - Booth #G56...
Continue Reading